You are here

  • Home
  • Archive
  • Volume 13, Issue 2
  • Cohort study finds nine times increased overdose risk (fatal plus non-fatal) in patients receiving 100 mg/day for 90 days compared with 1–20 mg/day opioids for chronic non-cancer pain, but wide CI and possibility of unmeasured confounders

Article info

Article menu
Download PDFPDF
Prognosis
Cohort study
Cohort study finds nine times increased overdose risk (fatal plus non-fatal) in patients receiving 100 mg/day for 90 days compared with 1–20 mg/day opioids for chronic non-cancer pain, but wide CI and possibility of unmeasured confounders

Authors

  1. Correspondence to Joel Simon Hochman
    Executive Director, National Foundation for the Treatment of Pain, 1714 White Oak Drive, Houston, TX 770099, USA; jfshmd{at}gmail.com
View Full Text

Citation

Hochman JS, Pergolizzi J
Cohort study finds nine times increased overdose risk (fatal plus non-fatal) in patients receiving 100 mg/day for 90 days compared with 1–20 mg/day opioids for chronic non-cancer pain, but wide CI and possibility of unmeasured confounders
Evidence-Based Nursing 2010;13:55-56.

Publication history

  • First published May 1, 2010.
Online issue publication 
August 31, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions